DRUG · Unmapped registry intervention
Dexamthasone
Find medicine records ·
Find other trials using this name
Clinical trial
Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy
NCT04037462
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedInduction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1, PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Immunotherapyunresolved
Interventions
DexamthasoneDRUG
Sponsors & collaborators
VA Office of Research and Developmentlead sponsor
Wayne State Universitycollaborator
University of Michigancollaborator
Barbara Ann Karmanos Cancer Institutecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04037462 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.